Skip to main content
. 2020 Sep 15;11:498758. doi: 10.3389/fphar.2020.498758
3-MA 3-methyladenine
AD Alzheimer disease
adFNDI autosomal-dominant familial neurohypophyseal diabetes insipidus
ADSCs Adipose tissue-derived stem cells
ADT2DM advanced duration of type 2 diabetes mellitus
ALK activin receptor-like kinase
AMPK 5′ adenosine monophosphate activated protein kinase
ATF6 activating transcription factor-6
ATG AuTophaGy related proteins
Atg7 autophagy-related gene 7
Bcl2 B-cell lymphoma 2
BUN blood urea nitrogen
CAT catalase
CNS central nervous system
CTGF connective tissue growth factor
DDIT3 DNA-damage inducible transcript 3
DM Diabetes mellitus
DN diabetic neuropathy
DRP1 Dynamin‐related protein 1
ECM extracellular matrix
EGFR/MAPK epidermal growth factor receptor/mitogen activated protein kinase
EIF2AK3 eukaryotic translation initiation factor 2 α kinase 3
EMT epithelial mesenchymal transition
ER endoplasmic reticulum
ERN1/Ire1α endoplasmic reticulum to nucleus signaling 1/inositol requiring enzyme-1α
Ex-4 exendin-4
FADD Fas-associated death domain protein
FGF21 fibroblast growth factor 21
FPI fasting blood insulin
FIP200 family interacting protein of 200 Kd
FN fibronectin
GABA γ-aminobutyric acid
GABARAPL1 GABA A receptor-associated protein like 1
GLP-1 glucagon-like peptide-1
GLP-1R glucagon-like peptide-1 receptor
GLUT 4 glucose transporter 4
GS glycine-serine-rich
GSH-Px glutathione peroxidase
GSK3 Glycogen synthase kinase 3
GTP guanosine triphosphatases
hIAPP human islet amyloid polypeptide
HIF1α hypoxia inducible factor 1-α
HIHG high insulin/glucose
HSC hepatic stellate cell
GDM gestational diabetes mellitus
iAs Inorganic arsenic
IR insulin receptor
pIRE1 IRE1 phosphorylation
JNK c-Jun N-terminal kinase
LC3 light chain 3
LTBP-1 latent transforming growth factor beta binding protein -1
LAMP-2 lysosome associated membrane protein2
LC3 1A/1B-light chain 3
LCIIIB light chain IIIB
MHC major histocompatibility complex
MAPK mitogen-activated protein kinase
MC Momordica charantia, MDA, malondialdehyde
MFN2 Mitofusin-2
MIN6 mouse INsulinoma 6
MMC mouse mesangial cells
MMP9 matrix metalloproteinase 9
mRNA messenger ribonucleic acid
mTOR mTORC2, rapamycin complex 2
mammalian target of rapamycin
NAC N‐acetylcysteine
NAFLD nonalcoholic fatty liver disease
ND non-diabetic
NF-kB nuclear factor kappa-B light-chain-enhancer of activated B cells
NDT2DM newly diagnosed type 2 diabetes mellitus
NO nitric oxide
NOD nonobese diabetic
NPC1L1 Niemann-Pick C1-like
OLETF Otsuka Long-Evans Tokushima Fatty
PEG-sTNF-RI pegylated soluble tumor necrosis factor receptor type 1
PPARγ peroxisome proliferator‐activated receptor γ
PBMCs peripheral blood mononuclear cells
PKA protein kinase A
pGDM prior history of gestational diabetes mellitus
PERK endoplasmic reticulum kinase
PI3P phosphatidyl inositol-3 phosphate, Rab, Ras-associated binding
RT-FQ-PCR real time fluorescence quantitative polymerase chain reaction analysis ROS, reactive oxygen species
rpWAT retroperitoneal white adipose tissues
scWAT subcutaneous white adipose tissues
SCr serum creatinine
SNARE SolubleN-ethylmaleimide-sensitive factor-attachment protein receptor; reactive oxygen species
SOD superoxide dismutase
STZ Streptozotocin
SRX sulfiredoxin
T2DM type 2 diabetes mellitus
TAK1 beta-activated kinase 1
TEM transmission electron microscopy
TGF-β transforming growth factor β
TNF-α tumor necrosis factor-α
TGN trans-Golgi network
TRAF6 Tumor necrosis factor receptor-associated factor 6
TUDCA tauroursodeoxycholic acid
ULK1 Unc-51-like kinase 1
UP urine protein
UPR unfolded protein response
UUO unilateral ureteral obstruction
VEGF vascular endothelial growth factor
Vps34 Vacuolar Protein Sorting Protein 34. WIPI, WD-repeat protein interacting with phosphoinositides.